GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Feb 2021 04:54 PM
RNS
Director/PDMR Shareholding
04 Feb 2021 11:15 AM
RNS
Director/PDMR Shareholding
03 Feb 2021 12:00 PM
RNS
Final Results
03 Feb 2021 07:00 AM
RNS
GSK/CureVac partner on new mRNA Covid-19 vaccines
01 Feb 2021 02:04 PM
RNS
Total Voting Rights
26 Jan 2021 04:26 PM
RNS
Director/PDMR Shareholding
22 Jan 2021 07:00 AM
RNS
FDA approves ViiV Healthcare's Cabenuva for HIV
20 Jan 2021 04:00 PM
RNS
Director/PDMR Shareholding
20 Jan 2021 03:50 PM
RNS
Director/PDMR Shareholding
20 Jan 2021 03:02 PM
RNS
Director/PDMR Shareholding
19 Jan 2021 06:02 PM
RNS
Director/PDMR Shareholding
18 Jan 2021 05:31 PM
RNS
Director/PDMR Shareholding
15 Jan 2021 04:00 PM
RNS
Director/PDMR Shareholding
15 Jan 2021 03:14 PM
RNS
Director/PDMR Shareholding
13 Jan 2021 01:45 PM
RNS
Director/PDMR Shareholding
11 Jan 2021 11:05 AM
RNS
Director/PDMR Shareholding
11 Jan 2021 09:16 AM
RNS
Director/PDMR Shareholding
04 Jan 2021 11:25 AM
RNS
Total Voting Rights
30 Dec 2020 11:52 AM
RNS
Director/PDMR Shareholding
23 Dec 2020 02:44 PM
RNS
Director/PDMR Shareholding
21 Dec 2020 07:00 AM
RNS
ViiV first long-acting HIV regimen approved in EU
11 Dec 2020 07:00 AM
RNS
Sanofi/ GSK update on COVID vaccine candidate
10 Dec 2020 05:51 PM
RNS
Director/PDMR Shareholding
10 Dec 2020 11:55 AM
RNS
Block Listing Application
09 Dec 2020 03:04 PM
RNS
Director/PDMR Shareholding
03 Dec 2020 05:53 PM
RNS
Director/PDMR Shareholding
01 Dec 2020 03:00 PM
RNS
Total Voting Rights
27 Nov 2020 02:58 PM
RNS
GSK publishes provisional 2021 dividend dates
26 Nov 2020 12:35 PM
RNS
EMTN Supplementary Prospectus
25 Nov 2020 10:26 AM
RNS
Director/PDMR Shareholding
23 Nov 2020 08:59 AM
RNS
Block listing Interim Review
19 Nov 2020 05:40 PM
RNS
Holding(s) in Company
17 Nov 2020 05:48 PM
RNS
Director/PDMR Shareholding
12 Nov 2020 01:00 PM
RNS
Medicago GSK phase 2/3 study start
11 Nov 2020 03:08 PM
RNS
Director/PDMR Shareholding
11 Nov 2020 11:13 AM
RNS
Director/PDMR Shareholding
09 Nov 2020 07:00 AM
RNS
ViiV's cabotegravir superior for HIV prevention
04 Nov 2020 05:32 PM
RNS
Director/PDMR Shareholding
04 Nov 2020 04:45 PM
RNS
Director/PDMR Shareholding
03 Nov 2020 04:09 PM
RNS
Director/PDMR Shareholding
03 Nov 2020 08:00 AM
RNS
GSK sets new environmental goals
02 Nov 2020 05:16 PM
RNS
Director/PDMR Shareholding
02 Nov 2020 03:59 PM
RNS
Total Voting Rights
30 Oct 2020 05:08 PM
RNS
Holding(s) in Company
30 Oct 2020 12:53 PM
RNS
Director/PDMR Shareholding
28 Oct 2020 05:46 PM
RNS
Director/PDMR Shareholding
28 Oct 2020 12:00 PM
RNS
3rd Quarter Results
28 Oct 2020 07:00 AM
RNS
Sanofi and GSK support COVAX - 200m vaccine doses
22 Oct 2020 12:34 PM
RNS
Holding(s) in Company
16 Oct 2020 12:18 PM
RNS
Positive CHMP opinion ViiV long-acting HIV regimen

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings